「fea」の検索結果

Discuss a community-edition product requirement with the user, draft a bilingual (Chinese + English) PRD for review, then — after explicit user approval — create the English-only issue on GitHub (<OWNER/REPO>). Use whenever the user wants to turn a requirement (from a Feishu doc, a meeting note, a customer ask, or a rough idea) into a GitHub issue. Triggers on phrases like "create requirement doc", "create a requirement", "put this requirement on GitHub", "create new feature issue", "draft an issue for...", or anytime the user describes a product feature/improvement they want tracked. The format is opinionated (Background / Goal / Spec / Verification / Related, NO implementation details, draft shown bilingually for human review, issue itself written in English only).

日本語の概要は準備中です。原文の説明を表示しています。

Build and verify Feature cards for Mobile-first interface with Bootstrap v5.3 using a working semantic implementation, responsive RTL/LTR behavior, theme tokens, test plan and design verification.

日本語の概要は準備中です。原文の説明を表示しています。

Build and verify Feature cards for Marketing landing with Bootstrap v5.3 using a working semantic implementation, responsive RTL/LTR behavior, theme tokens, test plan and design verification.

日本語の概要は準備中です。原文の説明を表示しています。

Build and verify Feature cards for Commerce and checkout with Bootstrap v5.3 using a working semantic implementation, responsive RTL/LTR behavior, theme tokens, test plan and design verification.

日本語の概要は準備中です。原文の説明を表示しています。

Build and verify Feature cards for Data-heavy application with Bootstrap v5.3 using a working semantic implementation, responsive RTL/LTR behavior, theme tokens, test plan and design verification.

日本語の概要は準備中です。原文の説明を表示しています。

Build and verify Feature cards for Documentation and knowledge with Bootstrap v5.3 using a working semantic implementation, responsive RTL/LTR behavior, theme tokens, test plan and design verification.

日本語の概要は準備中です。原文の説明を表示しています。

Implement, review, or improve SwiftUI features using the iOS 26+ Liquid Glass API. Use when asked to adopt Liquid Glass in new SwiftUI UI, refactor an existing feature to Liquid Glass, or review Liquid Glass usage for correctness, performance, and design alignment.

日本語の概要は準備中です。原文の説明を表示しています。

When the user wants to create or optimize in-app paywalls, upgrade screens, upsell modals, or feature gates. Also use when the user mentions "paywall," "upgrade screen," "upgrade modal," "upsell," "feature gate," "convert free to paid," "freemium conversion," "trial expiration screen," "limit reached screen," "plan upgrade prompt," or "in-app pricing." Distinct from public pricing pages (see page-cro) — this skill focuses on in-product upgrade moments where the user has already experienced value.

日本語の概要は準備中です。原文の説明を表示しています。

When the user wants to plan a product launch, feature announcement, or release strategy. Also use when the user mentions 'launch,' 'Product Hunt,' 'feature release,' 'announcement,' 'go-to-market,' 'beta launch,' 'early access,' 'waitlist,' or 'product update.' This skill covers phased launches, channel strategy, and ongoing launch momentum.

日本語の概要は準備中です。原文の説明を表示しています。

Frontend development guidelines for React/TypeScript applications. Modern patterns including Suspense, lazy loading, useSuspenseQuery, file organization with features directory, MUI v7 styling, TanStack Router, performance optimization, and TypeScript best practices. Use when creating components, pages, features, fetching data, styling, routing, or working with frontend code.

日本語の概要は準備中です。原文の説明を表示しています。

Master advanced AgentDB features including QUIC synchronization, multi-database management, custom distance metrics, hybrid search, and distributed systems integration. Use when building distributed AI systems, multi-agent coordination, or advanced vector search applications.

日本語の概要は準備中です。原文の説明を表示しています。

Insurance-industry App-in-Skill for read-only data governance, backed by an operator-provisioned Busabase workspace (one Drive node for the file drive plus four Bases for QA pairs, featured information, insurer notices, and user feedback) and trusted export/restore/PDF-text-backfill scripts. Use when the user invokes $kelly-insure-data or /kelly-insure-data, wants an insurance data workspace with UI, needs to review insurance files, metadata completeness, QA pairs, featured information, insurer notices, or user feedback, wants to back up or restore a Kelly Insure Data Busabase workspace from local PDFs, or wants Busabase Drive/Base data surfaced for data quality review and ongoing data governance.

日本語の概要は準備中です。原文の説明を表示しています。

Personal App-in-Skill voice-of-customer desk (Busabase App-in-Skill) aggregating user feedback from support email, Discord/Slack communities, X replies, app-store reviews, surveys, and interviews into clustered feature requests and a roadmap decision queue. Use when the user invokes $kelly-feedback or /kelly-feedback, or mentions user feedback, voice of customer, feature requests, roadmap decisions, feedback clustering, feedback triage, request dedupe, changelog replies, decline replies, or reviewing what users are asking for.

日本語の概要は準備中です。原文の説明を表示しています。

Analyzes encryption algorithms, key management, and file encryption routines used by ransomware families to assess decryption feasibility, identify implementation weaknesses, and support recovery efforts. Covers AES, RSA, ChaCha20, and hybrid encryption schemes. Activates for requests involving ransomware cryptanalysis, encryption analysis, key recovery assessment, or ransomware decryption feasibility.

日本語の概要は準備中です。原文の説明を表示しています。

Audit PostHog experiments and feature flags for configuration issues, staleness, and best-practice violations. Read when the user asks to audit, health-check, or review experiments or feature flags, check flag hygiene, or verify experiment setup.

日本語の概要は準備中です。原文の説明を表示しています。

Add feature flags to an application for gradual rollouts, A/B testing, and kill switches using PostHog, LaunchDarkly, or a simple local implementation.

日本語の概要は準備中です。原文の説明を表示しています。

Selects biomarker features from high-dimensional omics data using Boruta all-relevant selection, mRMR, LASSO/elastic-net, and stability selection, while controlling the leakage, irreproducibility, and correlated-feature traps that make most published signatures fail to replicate. Use when identifying candidate biomarkers, deciding between an all-relevant and a minimal-optimal selector, or judging whether a selected gene set is reproducible. For unbiased performance estimation of the resulting model see machine-learning/model-validation; for interpreting a trained model see machine-learning/prediction-explanation.

日本語の概要は準備中です。原文の説明を表示しています。

Builds diagnostic and prognostic classifiers on omics feature matrices with regularized logistic regression, random forest, and gradient-boosted trees, handling the p>>n regime, batch shortcut learning, class imbalance, and probability calibration. Use when building a classifier from expression, methylation, or variant data, choosing an algorithm for high-dimensional small-n data, or diagnosing a suspiciously perfect AUC. For unbiased evaluation see machine-learning/model-validation; for feature selection see machine-learning/biomarker-discovery; for time-to-event outcomes see machine-learning/survival-analysis.

日本語の概要は準備中です。原文の説明を表示しています。

Explains ML predictions on omics data with SHAP, LIME, and permutation importance, handling the correlated-feature trap, the conditional-vs-interventional Shapley choice, and the attribution-is-not-causation boundary. Use when interpreting an omics classifier, debugging shortcut/batch learning, or deciding whether an attribution ranking can be trusted as biology. For validated feature selection see machine-learning/biomarker-discovery; explanations are not a selection method.

日本語の概要は準備中です。原文の説明を表示しています。

Identify drug repurposing candidates via target-based, compound-based, and disease-based strategies. Combines drug-target-disease network reasoning with mechanism rationale, clinical-trial precedent, and patent/regulatory feasibility. Use for hypothesis-generating repurposing for orphan diseases, finding existing drugs for new indications, and prioritizing candidates by evidence and feasibility.

日本語の概要は準備中です。原文の説明を表示しています。

Molecular ML with diverse featurizers and pre-built datasets. Use for property prediction (ADMET, toxicity) with traditional ML or GNNs when you want extensive featurization options and MoleculeNet benchmarks. Best for quick experiments with pre-trained models, diverse molecular representations. For graph-first PyTorch workflows use torchdrug; for benchmark datasets use pytdc.

日本語の概要は準備中です。原文の説明を表示しています。

Runs the MS-DIAL preprocessing workflow (peak picking, MS2Dec spectral deconvolution, alignment, gap-filling) and imports the alignment-result table into R or Python with honest filtering. Use when preprocessing LC-MS DDA/DIA (SWATH) raw data with MS-DIAL, deciding MS-DIAL vs XCMS, configuring the MsdialConsoleApp console run, or parsing an MS-DIAL export into a clean feature matrix. For programmatic R peak detection and the feature-table-as-artifact framing see metabolomics/xcms-preprocessing; for lipid annotation mode see metabolomics/lipidomics; for MSI-level confidence honesty see metabolomics/metabolite-annotation; for drift correction and QC see metabolomics/normalization-qc.

日本語の概要は準備中です。原文の説明を表示しています。

Builds and applies 3D pharmacophore models using RDKit Pharm3D, the apo2ph4 receptor-based workflow (Heider et al 2022/2023 J Chem Inf Model 63:147-158), Pharmer / Pharmit (search), and PharmacoForge (diffusion-based generation, Flynn et al 2025 Front Bioinform), covering ligand-based pharmacophore (from active set alignment) and receptor-based pharmacophore (from binding pocket geometry). Explicit handling of feature types, geometric tolerances, partial matching, and pharmacophore-based virtual screening. Use when identifying scaffold-hopping candidates, building shape-and-feature search queries, or transferring SAR across chemotypes.

日本語の概要は準備中です。原文の説明を表示しています。

Performs retrosynthetic planning using AiZynthFinder (MCTS, template-based), Chemformer (template-free transformer), ASKCOS, and emerging RetroSynFormer with explicit handling of route scoring, building-block availability (eMolecules, Enamine, Mcule), forward prediction validation (Molecular Transformer), and disconnection-aware multi-objective search (MO-MCTS). Use when assessing synthetic feasibility of generated or selected molecules, planning multi-step syntheses, building synthesis-aware design pipelines, or screening libraries for retro-route feasibility.

日本語の概要は準備中です。原文の説明を表示しています。